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The Journal of Thoracic and Cardiovascular Surgery c Volume 144, Number 5 13ACameron D. Wright, MD, Boston, MassH
DExpert Review 998 Aprotinin revisited CAbe DeAnda, Jr, MD, and Bruce D. Spiess, MD, New York, NY, and Richmond, VaOne of the more controversial drugs used as an adjunct in cardiac surgery, aprotinin, is receiving
a second look because the study that resulted in removal of the drug from the US markets has been
found to have been flawed.Cardiothoracic Surgical
Education and Training
(EDU)
1003 Research incentive program for clinical surgical faculty associated with
increases in research productivityG
TSAnneke T. Schroen, MD, MPH, FACS, Monika J. Thielen, ART, BComm,
Florence E. Turrentine, PhD, Irving L. Kron, MD, and Craig L. Slingluff, Jr, MD,
Charlottesville, VaT/
B
SA research productivity scoring program was implemented for clinical surgical faculty to help
realign incentives to encourage and reward research. Productivity increases in publications and
grant funding were noted, suggesting that a formal incentive program could stimulate surgical
research. EAcquired Cardiovascular
Disease (ACD)
1010 Sutureless aortic valve replacement as an alternative treatment for patients
belonging to the ‘‘gray zone’’ between transcatheter aortic valve
implantation and conventional surgery: A propensity-matched, multicenter
analysisTX
Augusto D’Onofrio, MD, Antonio Messina, MD, Roberto Lorusso, MD, Ottavio R. Alfieri, MD,
Melissa Fusari, MD, Paolo Rubino, MD, Mauro Rinaldi, MD, Roberto Di Bartolomeo, MD,
Mattia Glauber, MD, Giovanni Troise, MD, and Gino Gerosa, MD, Padova, Brescia, Milan,
Mercogliano, Turin, Bologna, and Massa, ItalyMThis propensity-matched multicenter study was aimed at comparing clinical and
echocardiographic outcomes at hospital discharge of patients undergoing transapical aortic valve
implantation versus patients undergoing sutureless aortic valve replacement for severe
symptomatic aortic stenosis. Hospital mortality and major adverse events were similar between
groups, but sutureless aortic valve replacement was associated with a lower incidence of
paravalvular leak.)
P
Table of Contents (continued)ED
U
A
CD
CH
D
G
TS
ET/B
S
TX
PM114A The Journal of Thoracic an019 Very long-term results (up to 17 years) with the double-orifice mitral valve
repair combined with ring annuloplasty for degenerative mitral regurgitation(continued on page 16A
d Cardiovascular Surgery c November 2012Michele De Bonis, MD, Elisabetta Lapenna, MD, Roberto Lorusso, MD, PhD, Nicola Buzzati, MD,
Sandro Gelsomino, MD, PhD, Maurizio Taramasso, MD, Enrico Vizzardi, MD, and
Ottavio Alfieri, MD, Milan, Brescia, and Florence, ItalyThe long-term results of thedouble-orificemitral repair combinedwith ring annuloplasty are reported
in 174 patients with degenerative mitral regurgitation. At 14 years, freedom from reoperation was
89.6%6 2.51% and freedom from recurrence of mitral regurgitation$3+ was 83.8%6 3.39%,
confirming the satisfactory late outcomes of this technique in bileaflet and anterior leaflet prolapse.1027 A randomized comparison of the Saphenous Vein Versus Right Internal
Thoracic Artery as a Y-Composite Graft (SAVE RITA) trial: Early results
Ho Young Hwang, MD, PhD, Jun Sung Kim, MD, Se Jin Oh, MD, and Ki-Bong Kim, MD, PhD,
Seoul, KoreaEarly analysis of the SAVE RITA trial revealed that the saphenous vein composite graft was
comparable with the right internal thoracic artery composite graft in terms of early angiographic
patency (98.8% vs 99.5%; P 5 .629) and clinical outcomes.1036 The ‘‘no-dissection’’ technique is safe for reoperative aortic valve replacement
with a patent left internal thoracic artery graft
Tsuyoshi Kaneko, MD, Foeke Nauta, MS, Wernard Borstlap, MS, Siobhan McGurk, BSc,
James D. Rawn, MD, and Lawrence H. Cohn, MD, Boston, MassThe ‘‘no-dissection’’ technique avoids LITA graft dissection and uses systemic hypothermia and
hyperkalemia for myocardial protection. We compared patients with isolated reoperative AVRwith
a patent LITA graft using this technique with patients without a LITA graft. No differences were
found between the 2 groups in operative mortality or morbidity.1042 Selective antegrade cerebral perfusion and mild (28C-30C) systemic
hypothermic circulatory arrest for aortic arch replacement: Results from 1002
patients
Andreas Zierer, MD, Ali El-Sayed Ahmad, MD, Nestoras Papadopoulos, MD, Anton Moritz, MD,
Anno Diegeler, MD, and Paul P. Urbanski, MD, Frankfurt am Main and Bad Neustadt, GermanyDespite a growing tendency to increase the body temperature during circulatory arrest with
selective antegrade cerebral perfusion to up to 30C, the safe limits of this approach for spinal chord
and visceral organ protection are yet to be defined. Current data from 2 institutions of more than
1000 patients suggest that this approach can safely be applied to complex aortic arch surgery even
in a subgroup of patients with up to 90 minutes of selective antegrade cerebral perfusion.1051 Surgical ablation of atrial fibrillation trends and outcomes in North America
Niv Ad, MD, Rakesh M. Suri, MD, DPhil, James S. Gammie, MD, Shubin Sheng, PhD,
Sean M. O’Brien, PhD, and Linda Henry, PhD, Falls Church, Va, Rochester, Minn, Baltimore, Md,
and Durham, NCUsing the Society of Thoracic Surgeons Adult Cardiac Surgery Database, we examined the national
trends of surgical ablation and perioperative outcomes for stand-alone AF surgical ablation. The
prevalence of AF in patients undergoing cardiac surgery has increased and the concomitant
treatment of AF has declined. Isolated surgical ablations increased and were performed safely ‘‘on’’
or ‘‘off’’ bypass. Surgical AF ablation is an alternative to percutaneous ablation.)
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PM116A The Journal of Thoracic an061 Robotic total endoscopic double-vessel coronary artery bypass grafting—state
of procedure development(continued on page 18A
d Cardiovascular Surgery c November 2012Johannes Bonatti, MD, FETCS, Eric J. Lehr, MD, PhD, FRCSC, Thomas Schachner, MD,
Dominik Wiedemann, MD, Felix Weidinger, MD, Brody Wehman, MD, Andreas R. de Biasi, MD,
NikolaosBonaros,MD, PhD, FETCS, andBartleyGriffith,MD, Baltimore,Md, and Innsbruck, AustriaRobotic TECAB has been under development for 10 years. With increasing experience and
technological improvement, double-vessel TECAB has become feasible. The aim of the present
study was to compare the current outcomes of single- and double-vessel TECAB.1067 Pulmonary hypertension is associated with worse early and late outcomes after
aortic valve replacement: Implications for transcatheter aortic valve
replacement
Eric E. Roselli, MD, Anas Abdel Azim, MD, MSc, Penny L. Houghtaling, MS, Wael A. Jaber, MD,
and Eugene H. Blackstone, MD, Cleveland, OhioMost patients undergoing primary AVR have PHT that is not relieved by AVR; its severity is
associated with mortality, complications, and worse late survival. PHT severity should be included
in risk assessment before surgical intervention. These findings suggest earlier intervention for aortic
stenosis warrants further study.1075 Ten-year comparison of pericardial tissue valves versus mechanical prostheses
for aortic valve replacement in patients younger than 60 years of age
Alberto Weber, MD, Hassan Noureddine, MS, Lars Englberger, MD, Florian Dick, MD,
Brigitta Gahl, MS, Thierry Aymard, MD, Martin Czerny, MD, Hendrik Tevaearai, MD,
Mario Stalder, MD, and Thierry Pierre Carrel, MD, Berne, SwitzerlandThe selection of aortic valve prosthesis in patients under 60 years of age remains controversial. In
this study, we analyzed clinical outcomes after biologic and mechanical AVR in patients#60 years
of age.Congenital Heart
Disease (CHD)
1084 Aortic valve replacement in neonates and infants: An analysis of the Society of
Thoracic Surgeons Congenital Heart Surgery Database
Ronald K. Woods, MD, PhD, Sara K. Pasquali, MD, Marshall L. Jacobs, MD, Erle H. Austin, MD,
Jeffrey P. Jacobs, MD, Mary Krolikowski, MSN, RN, Michael E. Mitchell, MD,
Christian Pizarro, MD, and James S. Tweddell, MD, Milwaukee, Wis; Durham, NC; Cleveland,
Ohio; Louisville, Ky; St. Petersburg and Tampa, Fla; and Wilmington, DelNeonates and infants requiring aortic valve replacement are a high-risk group, particularly if
concomitant arch repair or postrepair mechanical circulatory support is required.1091 Size of the right ventricle-to-pulmonary artery conduit impacts mid-term
outcome after the Norwood procedure in patients weighing less than 3 kg
Naruhito Watanabe, MD, Petros V. Anagnostopoulos, MD, Takeshi Shinkawa, MD,
Natalie Johnson, BS, and Anthony Azakie, MD, San Francisco, CalifThe Norwood procedure with a 6-mm right ventricle-to-pulmonary artery conduit in patients
weighing ,3 kg may lead to better pulmonary artery growth and less need for pulmonary artery
intervention when compared with a 5-mm conduit.)
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PM118A The Journal of Thoracic an095 Surgical technical performance scores are predictors of late mortality and
unplanned reinterventions in infants after cardiac surgery(continued on page 20A
d Cardiovascular Surgery c November 2012Meena Nathan, MD, John M. Karamichalis, MD, Hua Liu, MS, Sitaram Emani, MD,
Christopher Baird, MD, Frank Pigula, MD, Steven Colan, MD, Ravi R. Thiagarajan, MBBS, MPH,
Emile A. Bacha, MD, and Pedro del Nido, MD, Boston, Mass, and New York, NYAlthough multiple perioperative factors determine the outcome of congenital cardiac surgery, TPS
serve as an important tool that not only measures the risk of early morbidity and greater resource
usage but also worse midterm outcomes.1102 Unloading of right ventricle by bidirectional superior cavopulmonary
anastomosis in hypoplastic left heart syndrome patients promotes remodeling
of systemic right ventricle but does not improve tricuspid regurgitation
Jelena Kasnar-Samprec, MD, PhD, Andreas K€uhn, MD, J€urgen H€orer, MD, PhD,
Manfred Vogt, MD, PhD, Julie Cleuziou, MD, R€udiger Lange, MD, PhD, and
Christian Schreiber, MD, PhD, Munich, GermanyThe relative size of the tricuspid annulus in patients with HLHS decreases after BSCPA, most likely
owing to volume unloading and remodeling of the systemic right ventricle. However, this
remodeling does not improve the grade of TR.1110 Twenty-four-hour ambulatory blood pressure monitoring detects a high
prevalence of hypertension late after coarctation repair in patients with
hypoplastic arches
Melissa G. Y. Lee, BMedSc, Remi Kowalski, MBBS, John C. Galati, PhD,
Michael M. H. Cheung, MBChB, Bryn Jones, MBBS, Jane Koleff, DipMedLabSc, and
Yves d’Udekem, MD, PhD, Melbourne, AustraliaEighteen years after coarctation repair, 60% of 62 patients with hypoplastic arches were shown to
be hypertensive by 24-hour blood pressure monitoring. Follow-up should include 24-hour blood
pressure monitoring because hypertension is not detected by casual resting measurements.1119 Congenital heart surgeon’s technical proficiency affects neonatal hospital
survival
Jeffrey Shuhaiber, MD, Kimberlee Gauvreau, ScD, Ravi Thiagarjan, MD, Emile Bacha, MD,
John Mayer, MD, Pedro del Nido, MD, and Frank Pigula, MD, Boston, MassContemporary risk factors for mortality after neonatal cardiac surgery have been seldom studied. In
this matched retrospective study based on a multivariate analysis, inadequate surgical repair or
palliation and need for postoperative extracorporeal membrane oxygenation were the main risk
factors for death.General Thoracic
Surgery (GTS)
1125 Robot-aided thoracoscopic thymectomy for early-stage thymoma:
A multicenter European study
Giuseppe Marulli, MD, PhD, Federico Rea, MD, Franca Melfi, MD, Thomas A. Schmid, MD,
Mahmoud Ismail, MD, Olivia Fanucchi, MD, Florian Augustin, MD, Marc Swierzy, MD,
Francesco Di Chiara, MD, Alfredo Mussi, MD, and Jens C. Rueckert, MD, Padova and Pisa, Italy;
Innsbruck, Austria; and Berlin, GermanyThoracoscopic thymectomy for stage I to stage II thymoma has been suggested in recent years, but
controversies still exist as a result of the lack of data on long-term results. This multicenter study
indicates that robot-enhanced thymectomy for early-stage thymoma is a safe procedure, but
a longer follow-up is needed to define the oncologic outcome.)
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PM120A The Journal of Thoracic an133 Lung transplantation in patients 70 years old or older: Have outcomes changed
after implementation of the lung allocation score?(continued on page 22A
d Cardiovascular Surgery c November 2012Arman Kilic, MD, Christian A. Merlo, MD, MPH, John V. Conte, MD, and Ashish S. Shah, MD,
Baltimore, MdThe present study evaluated whether the outcomes of LTx in recipients aged 70 years or older have
changed after implementation of the LAS. We found that age 70 years or older was associated with
increased mortality in the pre-LAS era but with comparable outcomes to those of patients aged 60
to 69 years in the LAS era.1139 Survival and quality of life at least 1 year after pneumonectomy
Ayesha S. Bryant, MD, Robert J. Cerfolio, MD, and Douglas J. Minnich, MD, Birmingham, AlaAlthough pneumonectomy is performed on carefully selected patients, their physical QOL score is
lower than the average population. The physical QOL score 1 year after resection was significantly
lower than that of the average population. However, the mental score in these patients, most of
whom had cancer, was higher.1146 Omental reinforcement of the thoracic esophagogastric anastomosis: An
analysis of leak and reintervention rates in patients undergoing planned and
salvage esophagectomy
Boris Sepesi, MD, Stephen G. Swisher, MD, Garrett L. Walsh, MD, Arlene Correa, PhD,
Reza J. Mehran, MD, David Rice, MD, Jack Roth, MD, Ara Vaporciyan, MD, and
Wayne L. Hofstetter, MD, Houston, TexWe evaluated the influence of omental anastomotic reinforcement on leak and reoperation rate in
patients undergoing esophagectomy with purely thoracic anastomoses. Use of omentum decreased
both overall leak rate and need to reoperate for a salvageable leak. We recommend reinforcing all
thoracic anastomoses with a pedicled omentum.1152 Differences in reported esophageal cancer resection outcomes between national
clinical and administrative databases
Damien J. LaPar, MD, MSc, George J. Stukenborg, MA, PhD, Christine L. Lau, MD,
David R. Jones, MD, and Benjamin D. Kozower, MD, MPH, Charlottesville, VaClinical and administrative databases report different outcomes after esophageal cancer resection.
This report establishes a reference for future comparisons and shows that the outstanding results of
the Society of Thoracic Surgeons Database are not representative of centers that do not participate.1160 Thoracoscopic localization of intraparenchymal pulmonary nodules using
direct intracavitary thoracoscopic ultrasonography prevents conversion of
VATS procedures to thoracotomy in selected patients
Mohamed Khereba, MD, Pasquale Ferraro, MD, Andre Duranceau, MD, Jocelyne Martin, MD,
MSc, Eric Goudie, Vicky Thiffault, BScN, and Moishe Liberman, MD, PhD, Montreal, Quebec,
CanadaThe study consisted of a prospective cohort of VATS-US for the localization of intraparenchymal
peripheral pulmonary nodules. The primary outcome measure was the prevention of conversion to
thoracotomy or lobectomy secondary to positive VATS-US findings in patients with nodules not
identifiable using standard VATS techniques. VATS-US prevented conversion to thoracotomy or
lobectomy without tissue diagnosis in 43% of cases.)
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PMEvolving Technology/
Basic Science (ET/BS)
122A The Journal of Thoracic an167 In vitro and in vivo therapeutic efficacy of CXCR4 antagonist BKT140 against
human non–small cell lung cancer(continued on page 24A
d Cardiovascular Surgery c November 2012Duha Fahham, MSc, Ido D. Weiss, PhD, Michal Abraham, PhD, Katia Beider, PhD,
Wald Hanna, Zippora Shlomai, MSc, Orly Eizenberg, PhD, Gideon Zamir, MD, Uzi Izhar, MD,
Oz M. Shapira, MD, Amnon Peled, PhD, and Ori Wald, MD, PhD, Jerusalem, IsraelCXCR4/CXCL12 interactions promote NSCLC carcinogenesis; thus, the CXCR4/CXCL12 axis
constitutes an attractive therapeutic target. We show that BKT140, a novel CXCR4 antagonist,
delays in vitro proliferation and in vivo growth of NSCLC cells. Furthermore, BKT140 augments
the antiproliferative effects of chemotherapy and radiotherapy.1176 Mechanical preconditioning enables electrophysiologic coupling of skeletal
myoblast cells to myocardium
Klaus Neef, PhD, Yeong-Hoon Choi, MD, Sureshkumar Perumal Srinivasan, MS,
Philipp Treskes, MS, Douglas B. Cowan, PhD, Christof Stamm, MD, Martin Rubach, MS,
Roland Adelmann, MD, Thorsten Wittwer, MD, and Thorsten Wahlers, MD, Cologne and Berlin,
Germany; and Boston, MassSkeletal myoblast–based engineered tissue constructs were used for in vitro transplantation to
viable embryonic heart slices. We show electrical coupling between mechanically preconditioned
myoblasts in the tissue constructs and myocardial cells in these ex vivo preparations, which may
lead toward therapeutic applications for the heart.1185 Knockdown of secretory phospholipase A2 IIa reduces lung cancer growth in
vitro and in vivo
Jessica A. Yu, MD, David Mauchley, MD, Howard Li, MD, Xianzhong Meng, MD, PhD,
Raphael A. Nemenoff, PhD, David A. Fullerton, MD, and Michael J. Weyant, MD, Aurora, ColoExpression of group IIa secretory phospholipase A2 was knocked down in lung cancer cells and
significantly reduced tumor growth in a xenograft model. These data support further exploration of
group IIa secretory phospholipase A2 as a potential therapeutic target in lung cancer.1192 Identification and characterization of stemlike cells in human esophageal
adenocarcinoma and normal epithelial cell lines
Ronghua Zhao, MD, PhD, Luca Quaroni, PhD, and Alan G. Casson, MB, ChB, MSc, FRCSC,
Saskatoon, Saskatchewan, Canada, and Villigen, SwitzerlandEsophageal cells were grown in serum-freemedia, and a comprehensive analysis of surfacemarkers,
clonogenicity, tumorigenicity, chemosensitivity, and gene expression was performed on parent and
spheroid cells. Enrichment for integrin a6bri/CD71dim and/or overexpression of Achaete-scute
complex homolog 2 suggests a subpopulation of stemlike cells in 3 human esophageal cell lines.Cardiothoracic
Transplantation (TX)
1200 Experience with the first 50 ex vivo lung perfusions in clinical transplantation
Marcelo Cypel, MD, MSc, Jonathan C. Yeung, MD, PhD, Tiago Machuca, MD, Manyin Chen, MD,
Lianne G. Singer, MD, Kazuhiro Yasufuku, MD, PhD, Marc de Perrot, MD, MSc,
Andrew Pierre, MD, MSc, Thomas K. Waddell, MD, PhD, and Shaf Keshavjee, MD, MSc, Toronto,
Ontario, CanadaNormothermic ex vivo lung perfusion of high-risk lungs from brain death and cardiac death donors
was performed in 58 donor lungs. Lungs from 50 donors were ultimately used for transplantation.
This strategy provided excellent outcomes after transplantation with a low incidence of primary
graft dysfunction grade 3 at 72 hours and a 1-year survival of 87%.)
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PM124A The Journal of Thoracic an208 Ex vivo rehabilitation of non–heart-beating donor lungs in preclinical porcine
model: Delayed perfusion results in superior lung function(continued on page 26A
d Cardiovascular Surgery c November 2012Daniel P. Mulloy, MD, Matthew L. Stone, MD, Ivan K. Crosby, MBBS, Damien J. LaPar, MD,
Ashish K. Sharma, MBBS, David V. Webb, MD, Christine L. Lau, MD, Victor E. Laubach, PhD, and
Irving L. Kron, MD, Charlottesville, VaLung transplantation is limited by the significant donor organ shortages. The results of the present
study have demonstrated that delayed ex vivo lung perfusion, after a period of cold static
preservation, is an effective treatment strategy for rehabilitation of uncontrolled non–heart-beating
donor lungs with extended warm ischemic times.1217 Utility of concomitant tricuspid valve procedures for patients undergoing
implantation of a continuous-flow left ventricular device
Valentino Piacentino III, MD, PhD, Asvin M. Ganapathi, MD, Mark Stafford-Smith, MD,
Michael K. Hsieh, BS, Chetan B. Patel, MD, Alan A. Simeone, MD, Joseph G. Rogers, MD, and
Carmelo A. Milano, MD, Durham, NCA concomitant tricuspid valve procedure appears to reduce postprocedure right ventricular failure
for patients with significant tricuspid regurgitation undergoing implantation of a continuous-flow
left ventricular assist device.1222 Transplantation of initially rejected donor lungs after ex vivo lung perfusion
Andreas Wallinder, MD, Sven-Erik Ricksten, MD, PhD, Christoffer Hansson, MSc,
Gerdt C. Riise, MD, PhD, Martin Silverborn, MD, PhD, Hans Liden, MD, PhD, Michael Olausson,
MD, PhD, and G€oran Dellgren, MD, PhD, Gothenburg, SwedenSix donor lungs unsuitable for lung transplantation underwent ex vivo lung perfusion and improved
their oxygenation capacity. Six patients underwent lung transplantation, and all survived and were
discharged fromthehospital. Theuseof exvivo lungperfusion seems safe and indicates that some lungs
refused for lung transplantation can be recovered and transplanted with acceptable short-term results.Perioperative
Management (PM)
1229 Amiodarone versus lidocaine and placebo for the prevention of ventricular
fibrillation after aortic crossclamping: A randomized, double-blind,
placebo-controlled trial
William J. Mauermann, MD, Juan N. Pulido, MD, David W. Barbara, MD, Martin D. Abel, MD,
Zhuo Li, MS, Laurie A. Meade, RN, Hartzell V. Schaff, MD, and Roger D. White, MD, Rochester,
MinnIn a randomized, double-blind, placebo-controlled trial, neither amiodarone nor lidocaine
decreased the incidence of ventricular fibrillation after aortic crossclamping. Amiodarone, but not
lidocaine, decreased the number of defibrillatory shocks required to terminate ventricular
fibrillation after aortic crossclamping.1235 Gentamicin collagen sponges for the prevention of sternal wound infection:
A meta-analysis of randomized controlled trials
Michael N. Mavros, MD, Pantelis K. Mitsikostas, MD, Vangelis G. Alexiou, MD, MSc,
George Peppas, MD, PhD, and Matthew E. Falagas, MD, MSc, DSc, Athens, Greece, Kettering,
United Kingdom, and Boston, MassA meta-analysis of randomized controlled trials evaluating gentamicin collagen sponges for the
prevention of postoperative SWI was performed. Gentamicin collagen sponges significantly
reduced deep and overall SWI rates, and surgically treated SWI; however, no effect was observed in
superficial SWI and mortality.)
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PM126A The Journal of Thoracic an241 Feasibility of landiolol and bisoprolol for prevention of atrial fibrillation after
coronary artery bypass grafting: A pilot study(continued on page 28A
d Cardiovascular Surgery c November 2012Akira Sezai, MD, PhD, Tishiko Nakai, MD, PhD, Mitsumasa Hata, MD, PhD,
Isamu Yoshitake, MD, PhD, Motomi Shiono, MD, PhD, Satoshi Kunimoto, MD, PhD, and
Atsushi Hirayama, MD, PhD, Tokyo, JapanWe examined whether perioperative intravenous landiolol and postoperative oral bisoprolol could
prevent AF after cardiac surgery. Both drugs were found to prevent postoperative AF, presumably
owing to their anti-ischemic, anti-inflammatory, and antioxidant effects.1249 Brain natriuretic peptide and risk of atrial fibrillation after thoracic surgery
David Amar, MD, Hao Zhang, MD, Weiji Shi, MS, Robert J. Downey, MD, Manjit S. Bains, MD,
Bernard J. Park, MD, Raja Flores, MD, Nabil Rizk, MD, Howard T. Thaler, PhD, and
Valerie W. Rusch, MD, New York, NYThe use of a BNP cutoff of 30 pg/mL or greater might help in identifying a subset of patients at the
greatest risk of developing POAFwhowouldmost benefit from stratified prophylactic interventions
and careful observation.Cardiothoracic
Imaging
1254 Six years after repair of a giant ascending aortic aneurysm
Khaled E. Al-Ebrahim, FRCSC, Jeddah, Saudi ArabiaSurgical Techniques 1256 Single-port sympathectomy for palmar hyperhidrosis with Vasoview Hemopro
2 endoscopic vein harvesting device
Calvin S. H. Ng, MD, FRCS(CTh), Eugene C. L. Yeung, MBBS, FRCS(CTh),
Randolph H. L. Wong, MBChB, FRCS(CTh), and Micky W. T. Kwok, MBChB, MRCS, Hong Kong,
China1257 Posterior pulmonary artery bifurcation side-to-side arterioplasty for branch
pulmonary artery stenosis
Jenelle A. Holst, BA, David N. Campbell, MD, James Jaggers, MD, and Max B. Mitchell, MD,
Aurora, Colo1260 Right ventricle–pulmonary artery conduit with intake port in the Norwood
procedure
Ryo Aeba, MD, and Ryohei Yozu, MD, Tokyo, Japan1262 Papillary heads ‘‘optimization’’ in repairing functional mitral regurgitation
Masashi Komeda, MD, PhD, Yutaka Koyama, Shunsuke Fukaya, and Hideki Kitamura, Nagoya,
Japan1264 Sutureless technique for recurrent pulmonary vein stenosis after pericardial
patchplasty in an adult
Masanori Hirota, MD, PhD, Joji Hoshino, MD, Yasuhisa Fukada, MD, and
Tadashi Isomura, MD, PhD, Kanagawa, Japan)
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PM128A The Journal of Thoracic an266 Two-stage surgical strategy for aortoesophageal fistula: Emergent thoracic
endovascular aortic repair followed by definitive open aortic and esophageal
reconstruction(continued on page 29A
d Cardiovascular Surgery c November 2012Prashanth Vallabhajosyula, MD, MS, Caroline Komlo, BS, Tyler Wallen, DO, and
Wilson Y. Szeto, MD, Philadelphia, PaBrief Research Report 1269 Aortic root and valve surgery after arterial switch operation
Tyson A. Fricke, BMedSci, Christian P. Brizard, MD, Yves d’Udekem, MD, PhD, and
Igor E. Konstantinov, MD, PhD, Melbourne, AustraliaOnline Only:
Case Reports
e111 Demonstration of persistent tumor cells 4 weeks after radiofrequency ablation
of a pulmonary adenocarcinoma
Stephane Renaud, Marco Schiavon, MD, Nicola Santelmo, MD, and Gilbert Massard, MD, PhD,
Strasbourg, Francee113 The role of methylene blue in serotonin syndrome following cardiac
transplantation: A case report and review of the literature
Kendra J. Grubb, MD, Jamie L. W. Kennedy, MD, James D. Bergin, MD,
Danja S. Groves, MD, PhD, and John A. Kern, MD, Charlottesville, Vae116 The reliability of lung function tests in a quadriplegic patient
Pierre Emmanuel Noly, MD, Alex Arame, MD, Marc Riquet, PhD, MD, and
Franc¸oise Le Pimpec-Barthes, PhD, MD, Paris, Francee117 Four-flap compound repair of thoracic hernia after sternum osteomyelitis and
omentum flap
Christian Dirk Taeger, MD, Ulrich Kneser, MD, and Raymund E. Horch, MD, Erlangen, Germanye119 Coronary artery thromboembolism as a result of left ventricular sump
aneurysm after congenital heart surgery
Timothy B. Cotts, MD, Felix J. Rogers, DO, Gisela C. Mueller, MD, and Sharlene M. Day, MD,
Ann Arbor and Trenton, Miche121 Delayed presentation of aortic laceration from seventh rib fracture: An
uncommon complication
Riley Kitamura, BA, Modesto Colon, MD, and Jasmine Dave, MD, New York, NYe123 Cardiac transapical approach: A new solution for the treatment of complex
thoracic aortic disease
Bruno Borrello, MD, Francesco Nicolini, MD, PhD, Andrea Agostinelli, MD, PhD, and
Tiziano Gherli, MD, Parma, ItalyLetters to the Editor 1272 Subcostal approach for replacement of failing circulatory pumps
Evgenij V. Potapov, MD, PhD, Thomas Krabatsch, MD, PhD, Michael H€ubler, MD, and
Roland Hetzer, MD, PhD, Berlin, Germany1272 EBUS-TBNA usage in diagnosing nodal metastases: A concern
Raymond A. Dieter, Jr, MD, and George B. Kuzycz, MD, Glen Ellyn, Ill)
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The Journal of Thoracic and Cardiovascular Surgery c Volume 144, Number 5 29AJamil Hajj-Chahine, MD, Christophe Jayle, MD, PhD, and Pierre Corbi, MD, PhD, Poitiers,
France1274 Reply to the Editor DCGianni D. Angelini, MD, and Michele Murzi, MD, Bristol, United KingdomA1274 Variable on treatment platelet reactivity in coronary artery bypass grafting
patients suggests the need for perioperative platelet function testing
Tomislav Kopjar, MD, Bojan Biocina, MD, PhD, and Mate Petricevic, MD, Zagreb, Croatia1275 Reply to the EditorDMarek A. Deja, MD, PhD, Tomasz Kargul, MD, and Wojciech Domaradzki, MD,
Katowice, PolandH1276 Sarcoidosis—no business of the bronchoscopist CManuel L. Ribeiro Neto, MD, Daniel A. Culver, DO, and Atul C. Mehta, MD, Cleveland, Ohio1277 Reply to the Editor
Masahide Oki, MD, and Hideo Saka, MD, Nagoya, Japan1TS277 Regarding ‘‘Vancouver simplified grading system with computed tomographic
angiography for blunt aortic injury’’GAli Azizzadeh, MD, and Anthony L. Estrera, MD, Houston, Tex1278 Reply to the Editor
Yoan Lamarche, MD, Ferco H. Berger, MD, and Michael T. Janusz, MD, Montreal, Quebec, and
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